Sorafenib is an oral multikinase inhibitor that inhibits tumor growth and proliferation by interfering with several receptor tyrosine kinases involved in the pathogenesis and perpetuation of ...

with Qilu and Shijiazhuang Pharmaceutical leading the way Zejing Biopharma's Class 1 anti-tumor new drug Donafenib Tosylate Tablets was approved for domestic listing ...

News, August 07, 2006 International Approvals: Sutent and Nexavar The EU has granted conditional approval for sunitinib malate capsules (Sutent) and it has approved sorafenib tosylate tablets ...